Publication | Closed Access

228MO PALOMA-4: Primary results from a phase III trial of palbociclib (PAL) + letrozole (LET) vs placebo (PBO) + LET in Asian postmenopausal women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative (ER+/HER2–) advanced breast cancer (ABC)

Breast OncologyMedicinePharmacologyPhase Iii TrialAsian Postmenopausal WomenBreast CancerPharmacotherapyAromataseCancer TreatmentOncologyRadiation OncologyCancer ResearchEndocrine-related CancerMenopause Hormone Therapy